Clinical Registry, Liver Transplantation
Conditions
Brief summary
The Institutional Registry of Liver Transplantation is a system for data collection related to patients with liver disease who are possible candidates for liver transplantion. This tool was designed by a multidisciplinary team that includes hepatologists, surgeons, informatics and biostatisticians. It intends to collect the information from the clinical evaluation, physical examination, complementary diagnostic methods and laboratory data. The information is captured sistematically, following structured, standardized and monitored processess to ensure the quality of the data obtained. The aim is to use the available technology to generate a complete database that can be used to answer research questions.
Interventions
PROCEDUREorthotopic liver transplantation
Sponsors
Hospital El Cruce
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Patients with indication for liver transplantation * Patients who are followed by the Liver Transplantation Unit of Hospital El Cruce
Exclusion criteria
* Patients who deny to participate after the informed consent process.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Time to mortality | 5 years | All patients are followed from the date of the inclusion to the registry, by periodic controls by the hepatologists and through telephones calls by the coordinator nurse, both before and after the transplantation. Every patient who dies during the 5 years of follow up will count as an event. Patients who are lost to follow up will be censored, in this case we will use the date of the last control or telephone call where he or she was alive. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Time to retransplantation | 5 years | We will considerate retransplantation as a competitive risk for death, calculating the time since the date of the transplant until the date of retransplantantion or not during the 5 years of follow up. |
Countries
Argentina
Contacts
Primary ContactLiliana P Rojas Saunero, MD
Backup ContactFederico G Villamil, MD
Outcome results
None listed